Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: The cardiovascular health study

JACC: Cardiovascular Imaging

Volumn 5, Issue 2, 2012, Pages 131-140

  Kalogeropoulos, Andreas P ^a   Georgiopoulou, Vasiliki V ^a   Defilippi, Christopher R ^b   Gottdiener, John S ^b   Butler, Javed ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

epidemiology; heart failure; risk prediction; risk score; risk stratification

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

AGED; BIOLOGICAL MARKERS; CARDIOMEGALY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK; RISK ASSESSMENT; VENTRICULAR FUNCTION, LEFT;

EID: 84857071493     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.11.011     Document Type: Article

References (39)

1. S. Hunt ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 e1 e82
2. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, D. Levy Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction N Engl J Med 336 1997 1350 1355 (Pubitemid 27208618)
3. J.M. Gardin, R. McClelland, D. Kitzman M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study) Am J Cardiol 87 2001 1051 1057 (Pubitemid 32710318)
4. G. Aurigemma, J. Gottdiener, L. Shemanski, J. Gardin, D. Kitzman Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study J Am Coll Cardiol 37 2001 1042 1048 (Pubitemid 32217604)
5. J.S. Gottdiener, D.W. Kitzman, G.P. Aurigemma, A.M. Arnold, T.A. Manolio Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the Cardiovascular Health Study) Am J Cardiol 97 2006 83 89 (Pubitemid 41828128)
6. G. de Simone, J. Gottdiener, M. Chinali, M. Maurer Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study Eur Heart J 29 2008 741 747 (Pubitemid 351431013)
7. D.A. Bluemke, R.A. Kronmal, J.A. Lima The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 52 2008 2148 2155
8. T.J. Wang, M.G. Larson, D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663 (Pubitemid 38364624)
9. C. deFilippi, R. Christenson, J. Gottdiener, W. Kop, S. Seliger Dynamic cardiovascular risk assessment in elderly people The role of repeated N-terminal pro-B-type natriuretic peptide testing J Am Coll Cardiol 55 2010 441 450
10. P. McKie, A. Cataliotti, B. Lahr The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects J Am Coll Cardiol 55 2010 2140 2147
11. J. Emberson, L. Ng, J. Armitage, L. Bowman, S. Parish, R. Collins N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF Heart Protection Study J Am Coll Cardiol 49 2007 311 319
12. T. Wang, D. Levy, E. Benjamin, R. Vasan The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening Ann Intern Med 138 2003 907 916
13. M. Redfield, R. Rodeheffer, S. Jacobsen, D. Mahoney, K. Bailey, J.J. Burnett Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study Circulation 109 2004 3176 3181
14. K. Bibbins-Domingo, M. Ansari, N.B. Schiller, B. Massie, M.A. Whooley Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study Am J Med 116 2004 509 516 (Pubitemid 38452641)
15. J. de Lemos, D. McGuire, A. Khera Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study Am Heart J 157 2009 74653.e2
16. J. Atherton Screening for left ventricular systolic dysfunction: is imaging a solution? J Am Coll Cardiol Img 3 2010 421 428
17. J. Butler, A. Kalogeropoulos, V. Georgiopoulou Incident heart failure prediction in the elderly: the Health ABC Heart Failure Score Circ Heart Fail 1 2008 125 133
18. A. Kalogeropoulos, B.M. Psaty, R.S. Vasan Cardiovascular Health Study Validation of the Health ABC heart failure model for incident heart failure risk prediction: the Cardiovascular Health Study Circ Heart Fail 3 2010 495 502
19. L.P. Fried, N.O. Borhani, P. Enright The Cardiovascular Health Study: design and rationale Ann Epidemiol 1 1991 263 276
20. B.M. Psaty, L.H. Kuller, D. Bild Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study Ann Epidemiol 5 1995 270 277
21. H. Blackburn Classification of the electrocardiogram for population studies: Minnesota Code J Electrocardiol 2 1969 305 310
22. J.M. Gardin, N.D. Wong, W. Bommer Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study J Am Soc Echocardiogr 5 1992 63 72
23. J.M. Gardin, D. Siscovick, H. Anton-Culver Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly The Cardiovascular Health Study Circulation 91 1995 1739 1748
24. R.M. Lang, M. Bierig, R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group J Am Soc Echocardiogr 18 2005 1440 1463
25. R.B. Devereux, D.R. Alonso, E.M. Lutas Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458 (Pubitemid 16119719)
26. D.G. Ives, A.L. Fitzpatrick, D.E. Bild Surveillance and ascertainment of cardiovascular events The Cardiovascular Health Study Ann Epidemiol 5 1995 278 285
27. G.D. Schellenbaum, S.R. Heckbert, N.L. Smith Congestive heart failure incidence and prognosis: case identification using central adjudication versus hospital discharge diagnoses Ann Epidemiol 16 2006 115 122 (Pubitemid 43197603)
28. C.T. Volinsky, A.E. Raftery Bayesian information criterion for censored survival models Biometrics 56 2000 256 262 (Pubitemid 30165117)
29. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 20712 (Pubitemid 351193639)
30. M.J. Pencina, R.B. D'Agostino, R.S. Vasan Statistical methods for assessment of added usefulness of new biomarkers Clin Chem Lab Med 48 2010 1703 1711
31. L. Chambless, C. Cummiskey, G. Cui Several methods to assess improvement in risk prediction models: extension to survival analysis Stat Med 30 2011 22 38
32. M.J. Pencina, R.B. D'Agostino Sr., E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
33. Y. Takemoto, M. Barnes, J. Seward Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function Am J Cardiol 96 2005 832 836 (Pubitemid 41317661)
34. A.M. From, C.G. Scott, H.H. Chen The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study J Am Coll Cardiol 55 2010 300 305
35. O. Nielsen, T. McDonagh, S. Robb, H. Dargie Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population J Am Coll Cardiol 41 2003 113 120 (Pubitemid 36044412)
36. M. Redfield, S. Jacobsen, J.J. Burnett, D. Mahoney, K. Bailey, R. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202 (Pubitemid 36068707)
37. P. Heidenreich, M. Gubens, G. Fonarow, M. Konstam, L. Stevenson, P. Shekelle Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction J Am Coll Cardiol 43 2004 1019 1026 (Pubitemid 38352983)
38. J. Smith, C. Newton-Cheh, P. Almgren Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation J Am Coll Cardiol 56 2010 1712 1719
39. R. Velagaleti, P. Gona, M. Larson Multimarker approach for the prediction of heart failure incidence in the community Circulation 122 2010 1700 1706